Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Natural Alternatives International Inc. (NAII:NASDAQ), powered by AI.
Natural Alternatives International Inc. is currently trading at $2.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Natural Alternatives International Inc. on Alpha Lenz.
Natural Alternatives International Inc.'s P/E ratio is -1.1.
“Natural Alternatives International Inc. trades at a P/E of -1.1 (undervalued) with modest ROE of -18.0%.”
Ask for details →Natural Alternatives International Inc. is a specialized company within the health and wellness industry, primarily focusing on the development, manufacturing, and marketing of nutritional supplements. Its core purpose is to offer custom nutritional products formulated with proprietary bioactive compounds, vitamins, minerals, and other health-specific ingredients. One of the company's notable features is its dedication to providing science-based solutions tailored to enhancing physical performance, cognitive function, and overall well-being. Natural Alternatives International operates a diversified portfolio serving various sectors such as sports nutrition, weight management, and lifestyle improvement, catering to both individual consumers and businesses. With a significant presence in research and development, the company plays a crucial role in advancing innovative nutraceutical technologies and maintaining high-quality standards across its manufacturing processes. Headquartered in California, it contributes significantly to the global market dynamics in the nutritional supplement sector, emphasizing sustainability and efficacy in health product solutions.
“Natural Alternatives International Inc. trades at a P/E of -1.1 (undervalued) with modest ROE of -18.0%.”
Ask for details →Natural Alternatives International Inc. (ticker: NAII) is a company listed on NASDAQ in the Consumer Defensive sector (Packaged Foods). It has approximately 296 employees. Market cap is $15M.
The current price is $2.5 with a P/E ratio of -1.1x and P/B of 0.22x.
ROE is -17.98% and operating margin is -5.59%. Annual revenue is $130M.